JAK2 and Wernicke encephalopathy: Fedratinib—an anticancer agent inhibiting Janus kinase 2 (JAK2)—blocks the essential intestinal thiamine transporter THTR2 and plays a crucial role in the onset of Wernicke’s encephalopathy.